13.45 | 10.45 Panel Discussion: Global Market Access To Liquid Biopsies

Time: 1:45 pm
day: Day Three


  • Looking at regulatory and reimbursement across different geographies for liquid biopsy implementation into the clinic
  • Where are we seeing the greatest adoption and why are there variations between geographies?
  • What is needed to highlight the value of these assays and further the delivery of precision medicine in different geographies?
  • How can drug developers successfully launch drug and assay in global markets to see a greater
    commercial return?
  • What are the major restraints to the wider application of liquid biopsies globally and how can these be addressed